Sign In
NewsRadar

Search Press
Looking for press releases of a particular company? Enter company name (or keyword) here.

   


BAC BV collaborates with Life Technologies to provide new HPLC affinity columns


Naarden, The Netherlands, 21 June 2011 – BAC BV, the leading provider of antibody-based affinity purification technology, has announced a strategic collaboration with Life Technologies, the global manufacturer of molecular diagnostic and research-use products, to bring the wide range of BAC’s CaptureSelect® affinity ligand specificities to Life Technologies’ POROS® chromatography media and pre-packed HPLC columns. This new suite of products will provide an unparalleled range of specificities and column formats for applications from discovery through to process monitoring.

The collaboration will create a range of ready-to-use HPLC columns pre-packed with CaptureSelect affinity ligands immobilized on POROS chromatography media. Designed for the high pressures and flow rates necessary to provide the real-time results demanded for biopharmaceutical quality assurance needs, the unique selectivity of these columns will support Process Analytical Technology (PAT) for virtually any biopharmaceutical manufacturing process.

“We are very excited to be able to provide a continuously evolving range of specificities and column formats that will allow more researchers to access the benefits of CaptureSelect technology”, commented Laurens Sierkstra, CEO of BAC. “Scientists will be able to routinely use CaptureSelect ligands in formats that support QbD approaches for process development and monitoring.”

--ends--

About BAC BV
BAC discovers, develops and manufactures affinity ligands and affinity purification products to support biopharmaceutical research and production. BAC’s CaptureSelect affinity purification and separation products are provided for the discovery, preclinical and clinical manufacturing of therapeutic proteins, including antibodies and antibody fragments. These products enable a reduced time to market, increased purity and yield and an overall lower cost of goods for biopharmaceutical drug development. BAC BV was established in 1995 as a Unilever subsidiary. Currently the Company employs 37 people with an R&D laboratory facility in Leiden and a state-of-the-art ISO 9001 certified manufacturing plant in Naarden, the Netherlands.
For more information about BAC, visit our website at www.bacbv.com. For more information about CaptureSelect® products, visit our website at www.captureselect.com.


For additional information, please contact:

College Hill Life Sciences
Dr Lynne Trowbridge, Dr Anastasios Koutsos
BAC@collegehill.com
+44 20-7457-2020


Publisher Contact Information:

College Hill Life Sciences
+44 20-7457-2020
BAC@collegehill.com

Company profile of Bio Affinity Company (BAC) (acquired by Life Technologies)
Past press releases of Bio Affinity Company (BAC) (acquired by Life Technologies).

Data


25,894
Tech investments
From our Online Data Service
16,759
VC-backed companies
From our Radar


Recent Deals


DATEAMOUNTSECTOR
Jun 29€1.3MSecurity
Jun 28€2.2MDatabase
Jun 28€12.0MMaterials
Jun 28€5.5MBusiness applications
Jun 27€3.0MBiopharmaceuticals
Jun 27€10.0MEnergy related
Jun 27N/AWireless applications

For information on Europe's most extensive database on technology funding click here!

Events



Press Releases


May 28
Identiq
identiq raises $5m seed, launches privacy-first identity validation...

Apr 29
Nethone
nethone raised over $1 million from innovation nest

Oct 1
The Link App
the link app launches version 2.0

Mar 29
Addex Therapeutics
addex sucessfully raises chf40 million in capital increase

Jan 2
Urban Jungle
urban jungle raises £1m in seed funding to build tech-enabled home ...





About usContact usLegal Information
Copyright © 1999-2019
Emerging Technology Research Europe Inc. All rights reserved.